Clinical trial · Interventional
Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer
Study Protocol for the Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Myeloma and Lymphoma During Stem Cell Transplant: a Pilot Randomized Clinical Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Research into cancer patients has shown that quality of life is significantly altered by the disease and its associated treatments and is also reported to be a predictor of significant emotional distress. Blood cancer patients are among those most affected in terms of quality of life, facing stem cell transplantation after high-dose chemotherapy, a treatment that is recognized as one of the most stressful of cancer therapy, due to the many adverse effects, including pain, and the uncertainty linked to the fear of graft failure. Hypnosis interventions are proving effective in treating common side effects: nausea, pain, fatigue, anxiety, depressive symptoms and improving overall quality of life, and other interventions, based on virtual reality, have shown promising effects on patients' distress and acute pain. The aim of this study is to evaluate the effects of an intervention program combining hypnosis and virtual reality in assisting myeloma and lymphoma patients during stem cell transplantation, with a view to improving their quality of life during this period. The project aims to assess the validity of the intervention, and to evaluate the effects of the intervention on patients' anxiety, pain and fatigue during transplantation. The validity of the intervention will be measured by a questionnaire assessing the relevance and acceptability of the intervention, expected effects, and practical implementation. Socio-demographic and clinical data will be collected from patients, including axiety, pain, fatigue and quality of life, studied at pre (one week after transplantation) and post (one month after transplantation) intervnention, and at follow-up (three month after transplantation).
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Blood Cancer | Liquid Tumor | ALIAS | 0.90 |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Multiple Myeloma (MM) | Multiple Myeloma | CURATED_EXACT | 0.85 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Virtual Reality Hypnosis | Device | — | UNRESOLVED |
| VRH : Beach | Device | — | UNRESOLVED |
| VRH : Forest | Device | — | UNRESOLVED |
| VRH : MagicHand | Device | — | UNRESOLVED |
| VRH : SecurityProtection | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention (VRH) group
- description
- Four obligatory accompanied session of VRH and use of VRH as needed.
- interventionNames
- Device: Virtual Reality Hypnosis
- Device: VRH : Beach
- Device: VRH : Forest
- Device: VRH : MagicHand
- Device: VRH : SecurityProtection
- type
- NO_INTERVENTION
- label
- Control group
- description
- Standard of care (waiting list, will receive VRH following the study).
Primary outcomes (2)
- measure
- Anxiety and depression
- timeFrame
- Studied one week, one month and three months post-transplantation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Being 18 years of age or older * Suffering from multiple myeloma or lymphoma eligible for transplant * Understanding French Exclusion Criteria: * Deafness * Blindness * Confusion or psychopathological disorders (for example, schizophrenia) that may impair communication
References
Publications (1)
- DERIVEDLaurin A, Rousseaux F, Fournier V, Roy J, Landry M, LeBlanc R, Godin N, Arbour C, Richebe P, Jerbi K, Rainville P, Ogez D. Using virtual reality hypnosis during stem cell transplant for patients in hematology: A protocol for a feasibility randomized study. PLoS One. 2026 Feb 27;21(2):e0338617. doi: 10.1371/journal.pone.0338617. eCollection 2026. PMID 41758815